ID FCERB_HUMAN Reviewed; 244 AA. AC Q01362; Q54A81; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 17-JUN-2020, entry version 167. DE RecName: Full=High affinity immunoglobulin epsilon receptor subunit beta; DE Short=FcERI; DE AltName: Full=Fc epsilon receptor I beta-chain; DE AltName: Full=IgE Fc receptor subunit beta; DE AltName: Full=Membrane-spanning 4-domains subfamily A member 2; GN Name=MS4A2; Synonyms=APY, FCER1B, IGER; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=1535625; RA Kuester H., Zhang L., Brini A.T., Macglashan D.W., Kinet J.-P.; RT "The gene and cDNA for the human high affinity immunoglobulin E receptor RT beta chain and expression of the complete human receptor."; RL J. Biol. Chem. 267:12782-12787(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1386024; DOI=10.1016/0014-5793(92)80430-o; RA Maekawa K., Imagawa N., Tanaka Y., Harada S.; RT "Determination of the sequence coding for the beta subunit of the human RT high-affinity IgE receptor."; RL FEBS Lett. 302:161-165(1992). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=12697656; DOI=10.1093/intimm/dxg055; RA Akizawa Y., Nishiyama C., Hasegawa M., Maeda K., Nakahata T., Okumura K., RA Ra C., Ogawa H.; RT "Regulation of human FcepsilonRI beta chain gene expression by Oct-1."; RL Int. Immunol. 15:549-556(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP VARIANT GLY-237, AND INVOLVEMENT IN ATOPIC ASTHMA SUSCEPTIBILITY. RX PubMed=8817330; DOI=10.1093/hmg/5.7.959; RA Hill M.R., Cookson W.O.; RT "A new variant of the beta subunit of the high-affinity receptor for RT immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of RT atopy and bronchial hyper-responsiveness."; RL Hum. Mol. Genet. 5:959-962(1996). RN [6] RP VARIANT GLY-237, AND INVOLVEMENT IN ATOPIC ASTHMA SUSCEPTIBILITY. RX PubMed=8842731; DOI=10.1093/hmg/5.8.1129; RA Shirakawa T., Mao X.-Q., Sasaki S., Enomoto T., Kawai M., Morimoto K., RA Hopkin J.; RT "Association between atopic asthma and a coding variant of Fc-epsilon-RI- RT beta in a Japanese population."; RL Hum. Mol. Genet. 5:1129-1130(1996). RN [7] RP ERRATUM OF PUBMED:8842731. RX PubMed=8968765; RA Shirakawa T., Mao X.-Q., Sasaki S., Enomoto T., Kawai M., Morimoto K., RA Hopkin J.; RL Hum. Mol. Genet. 5:2068-2068(1996). CC -!- FUNCTION: High affinity receptor that binds to the Fc region of CC immunoglobulins epsilon. Aggregation of FCER1 by multivalent antigens CC is required for the full mast cell response, including the release of CC preformed mediators (such as histamine) by degranulation and de novo CC production of lipid mediators and cytokines. Also mediates the CC secretion of important lymphokines. Binding of allergen to receptor- CC bound IgE leads to cell activation and the release of mediators CC responsible for the manifestations of allergy. CC -!- SUBUNIT: Tetramer of an alpha chain, a beta chain, and two disulfide CC linked gamma chains. Binds LILRB1. Interacts with FGR, FES/FPS and LYN CC (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q01362; Q8N2M4: TMEM86A; NbExp=5; IntAct=EBI-13384102, EBI-12015604; CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Found on the surface of mast cells and basophils. CC -!- PTM: Phosphorylated on tyrosine residues by LYN. {ECO:0000250}. CC -!- POLYMORPHISM: Variant Glu-237 has been found to be present in about CC 5.3% of a 1004 individuals population sample in Australia CC (PubMed:8817330). {ECO:0000269|PubMed:8817330}. CC -!- SIMILARITY: Belongs to the MS4A family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D10583; BAA01440.1; -; mRNA. DR EMBL; M89796; AAA60269.1; -; Genomic_DNA. DR EMBL; AB080913; BAC66486.1; -; Genomic_DNA. DR EMBL; BC074800; AAH74800.1; -; mRNA. DR EMBL; BC074843; AAH74843.1; -; mRNA. DR CCDS; CCDS7980.1; -. DR PIR; A42806; A42806. DR RefSeq; NP_000130.1; NM_000139.4. DR RefSeq; XP_011543152.1; XM_011544850.2. DR SMR; Q01362; -. DR BioGRID; 108500; 4. DR CORUM; Q01362; -. DR IntAct; Q01362; 1. DR STRING; 9606.ENSP00000278888; -. DR DrugBank; DB00043; Omalizumab. DR TCDB; 1.A.37.3.2; the cd20 ca(2+) channel (cd20) family. DR iPTMnet; Q01362; -. DR PhosphoSitePlus; Q01362; -. DR BioMuta; MS4A2; -. DR DMDM; 232084; -. DR MassIVE; Q01362; -. DR PaxDb; Q01362; -. DR PeptideAtlas; Q01362; -. DR PRIDE; Q01362; -. DR ProteomicsDB; 57942; -. DR ABCD; Q01362; 2 sequenced antibodies. DR Antibodypedia; 27859; 72 antibodies. DR Ensembl; ENST00000278888; ENSP00000278888; ENSG00000149534. DR GeneID; 2206; -. DR KEGG; hsa:2206; -. DR UCSC; uc001nop.4; human. DR CTD; 2206; -. DR DisGeNET; 2206; -. DR EuPathDB; HostDB:ENSG00000149534.8; -. DR GeneCards; MS4A2; -. DR HGNC; HGNC:7316; MS4A2. DR HPA; ENSG00000149534; Tissue enriched (blood). DR MalaCards; MS4A2; -. DR MIM; 147138; gene. DR neXtProt; NX_Q01362; -. DR OpenTargets; ENSG00000149534; -. DR PharmGKB; PA31109; -. DR eggNOG; ENOG410J28C; Eukaryota. DR eggNOG; ENOG4111DU9; LUCA. DR GeneTree; ENSGT00940000161985; -. DR HOGENOM; CLU_093202_0_0_1; -. DR InParanoid; Q01362; -. DR KO; K08090; -. DR OMA; MACFSTE; -. DR OrthoDB; 1048914at2759; -. DR PhylomeDB; Q01362; -. DR TreeFam; TF335157; -. DR Reactome; R-HSA-2454202; Fc epsilon receptor (FCERI) signaling. DR Reactome; R-HSA-2730905; Role of LAT2/NTAL/LAB on calcium mobilization. DR Reactome; R-HSA-2871796; FCERI mediated MAPK activation. DR Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization. DR Reactome; R-HSA-2871837; FCERI mediated NF-kB activation. DR SignaLink; Q01362; -. DR SIGNOR; Q01362; -. DR BioGRID-ORCS; 2206; 4 hits in 787 CRISPR screens. DR GeneWiki; MS4A2; -. DR GenomeRNAi; 2206; -. DR Pharos; Q01362; Tbio. DR PRO; PR:Q01362; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; Q01362; protein. DR Bgee; ENSG00000149534; Expressed in fundus of stomach and 99 other tissues. DR ExpressionAtlas; Q01362; baseline and differential. DR Genevisible; Q01362; HS. DR GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl. DR GO; GO:0032998; C:Fc-epsilon receptor I complex; IEA:Ensembl. DR GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0019863; F:IgE binding; IEA:UniProtKB-KW. DR GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome. DR GO; GO:0006955; P:immune response; IMP:UniProtKB. DR GO; GO:0006954; P:inflammatory response; IEA:InterPro. DR InterPro; IPR007237; CD20-like. DR InterPro; IPR030417; MS4A. DR InterPro; IPR030420; MS4A2. DR PANTHER; PTHR23320; PTHR23320; 1. DR PANTHER; PTHR23320:SF66; PTHR23320:SF66; 1. DR Pfam; PF04103; CD20; 1. PE 1: Evidence at protein level; KW Disulfide bond; IgE-binding protein; Membrane; Phosphoprotein; KW Polymorphism; Receptor; Reference proteome; Transmembrane; KW Transmembrane helix. FT CHAIN 1..244 FT /note="High affinity immunoglobulin epsilon receptor FT subunit beta" FT /id="PRO_0000158629" FT TOPO_DOM 1..59 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 60..79 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 80..97 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 98..117 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 118..130 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 131..150 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 151..180 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 181..200 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 201..244 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT MOD_RES 219 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P20490" FT MOD_RES 225 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P20490" FT MOD_RES 226 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P20490" FT MOD_RES 229 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P20490" FT VARIANT 143 FT /note="T -> M (in dbSNP:rs35033981)" FT /id="VAR_053515" FT VARIANT 211 FT /note="N -> K (in dbSNP:rs535630)" FT /id="VAR_053516" FT VARIANT 237 FT /note="E -> G (polymorphism; risk factor for atopic FT dermatitis and asthma; dbSNP:rs569108)" FT /evidence="ECO:0000269|PubMed:8817330, FT ECO:0000269|PubMed:8842731" FT /id="VAR_003965" SQ SEQUENCE 244 AA; 26534 MW; CE523102D5F567AF CRC64; MDTESNRRAN LALPQEPSSV PAFEVLEISP QEVSSGRLLK SASSPPLHTW LTVLKKEQEF LGVTQILTAM ICLCFGTVVC SVLDISHIEG DIFSSFKAGY PFWGAIFFSI SGMLSIISER RNATYLVRGS LGANTASSIA GGTGITILII NLKKSLAYIH IHSCQKFFET KCFMASFSTE IVVMMLFLTI LGLGSAVSLT ICGAGEELKG NKVPEDRVYE ELNIYSATYS ELEDPGEMSP PIDL //